Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models - Wikidata - wikimedia - TriplyDB

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models

http://www.wikidata.org/entity/Q34022920

about

Ketogenic Diets: An Update for Child Neurologists Chronic ingestion of 2-deoxy-D-glucose induces cardiac vacuolization and increases mortality in rats Mitochondrial involvement and oxidative stress in temporal lobe epilepsy Harnessing the power of metabolism for seizure prevention: focus on dietary treatments Metabolic Therapy for Temporal Lobe Epilepsy in a Dish: Investigating Mechanisms of Ketogenic Diet using Electrophysiological Recordings in Hippocampal Slices Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures.Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels.Non-ketogenic combination of nutritional strategies provides robust protection against seizures.Glycolysis in energy metabolism during seizures.Ketogenic diets and pain.Potent anti-seizure effects of D-leucine.Ketogenic diets: from cancer to mitochondrial diseases and beyond.Ketogenic diets: evidence for short- and long-term efficacy.Purines and the Anti-Epileptic Actions of Ketogenic Diets.Mitochondrial respiration deficits driven by reactive oxygen species in experimental temporal lobe epilepsy.The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy.Ketogenic diets, mitochondria, and neurological diseases.Dietary therapies for epilepsy and other neurological disorders: highlights of the 3rd international symposium.2-Deoxy-d-Glucose (2-DG)-Induced Cardiac Toxicity in Rat: NT-proBNP and BNP as Potential Early Cardiac Safety Biomarkers Finding a better drug for epilepsy: antiepileptogenesis targets.Alterations of hippocampal glucose metabolism by even versus uneven medium chain triglycerides.New and investigational antiepileptic drugs.Golgi apparatus dis- and reorganizations studied with the aid of 2-deoxy-D-glucose and visualized by 3D-electron tomography.Triheptanoin--a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment?Neuroprotection in metabolism-based therapy.Ketogenic diets: new advances for metabolism-based therapies.Mechanisms of physiological and epileptic HFO generation.The ketogenic diet in pharmacoresistant childhood epilepsy.How does the ketogenic diet work? Four potential mechanisms The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction.Glycolytic inhibition by 2-deoxy-d-glucose abolishes both neuronal and network bursts in an in vitro seizure model.Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII).Alternative Fuels in Epilepsy and Amyotrophic Lateral Sclerosis.The Epigenetics of Epilepsy and Its Progression.Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment.Glycolysis Inhibition: The Gift of GAB(A)Posttraumatic Epilepsy: What's Contusion Got to Do With It?Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models Effect of low Mg2+ and bicuculline on cell survival in hippocampal slice cultures.

P2860

Q22299266-6C5D390C-463B-468F-A11E-C3A9EF73C0E1 Q24634601-038A1CFC-F07A-460C-B8C3-539DBE7CB316 Q26865259-183D426F-5E6F-461D-9EAE-F30B16F4C08C Q26991869-70329EE1-F224-4E28-8F90-2DA9E9CCF0D7 Q28071552-B8E4DAB7-9282-45B1-B791-7A8EF10324E3 Q28272457-FF20095C-5D4F-4F98-8315-11D7FC3100F9 Q30514237-60A35B5D-CA08-497F-AF1A-1B82F1AF324E Q33857877-630FBC83-9C07-40C2-A763-D6D8BB64D095 Q33905611-38E87882-7873-4388-99A1-97B9E423BFBA Q33937088-44B6DB47-E0AE-4E05-89B8-A56187F69BEC Q34014157-9D316DC1-8C5B-4DFC-87AE-CC5E1EBFE376 Q34479759-1FC8EE35-FA47-4C65-8202-896319285E8F Q34509699-5E783842-68E9-4292-B9EF-D410E9200368 Q34971377-2B9BB2AA-F1E1-4593-A2B6-91FF8F534735 Q35513799-8B65F0D6-3124-47EB-A37B-CFAA20FADAD0 Q35736503-CC52F380-CF09-415A-8F4D-2B3D14EDC592 Q35852049-6030C043-5800-4E45-B149-E96D9B0313E3 Q36196765-75BD7C31-3407-40A6-BC52-8D95D976497C Q36804600-44ACD1AB-AA99-471D-9FE5-4B47E77DB700 Q36892819-9E4B52E7-6269-49BD-A90F-D5BD97140457 Q37232240-E1020F81-E806-4146-BEE5-A480A3F0C841 Q37459904-D0D4DE17-BA66-4986-BCD7-FC7390D46F04 Q37638688-B48E5EDB-F8B2-49D0-9F56-6546C975A6B7 Q37712748-48F694E9-88C5-4043-9D6F-4C43B8F4B6C1 Q37920144-6DD86FA4-3604-429D-B531-6C4D50C48E4F Q37923014-FB39493D-588C-4905-836B-EBC99E08BFE7 Q37982950-6ACD27E7-3F94-47D4-BAF1-D26DAB3E759D Q37993959-7CC23C47-1B29-4FDB-8AD2-BB23F8E83C47 Q38494270-106B91F0-F453-4748-9EC3-A8BC1C11F163 Q38582924-6667C90D-BAB3-4659-A9C6-C969163D7219 Q38809233-62FBD4C8-6C6E-4E8C-BFCC-A00B2B50825E Q38839414-D312F36A-A445-4915-B47C-AB684AEEE89A Q39006241-5AFDF819-14DE-4911-94D3-EC6B54AB2CB3 Q39014987-366738EF-7EDC-4A1C-BBC1-F4BB162D2D86 Q39281184-EDD2AD97-1BD4-4E32-BB32-7DB92CDF8F6F Q41984278-66C41445-55E5-450B-87A1-813DCD860614 Q42084996-6461E94C-567F-43A1-8051-B8F81DBCA9DA Q42183961-DB9064B8-8AEB-4638-AC6E-D9E6CC3080C2 Q42409348-29E541CC-875D-48F2-A727-04DA8C3F4D7A Q42860444-3977FA3C-0D69-473F-A29E-699DCA10FF03

P2860

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models

http://www.wikidata.org/entity/Q34022920

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models

@ast

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models

@en

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models

@nl

type

label

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models

@ast

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models

@en

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models

@nl

prefLabel

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models

@ast

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models

@en

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models

@nl

P1433

Q34022920-6A3724C3-9030-4D6F-9447-8F96E06AB71E

P1476

Q34022920-564260D8-0143-47FF-B36D-F4D2D03B55A7

P2093

Q34022920-0F780346-9F14-47BA-A7ED-4F3E504409A6

Q34022920-79878BAE-589B-47F9-A923-BDFD1542F723

Q34022920-8C195449-6460-4DEE-A624-C9176780FAF7

Q34022920-B31669E3-A6BA-45D4-9EF8-59C683825932

Q34022920-CFA0AB14-8D1E-49AA-8BCE-F5D8F88073B4

P2860

Q34022920-007EE153-3709-48FB-BD44-FB0B380CB1BA

Q34022920-041D5761-B922-4186-BC7B-EEA6355DCE98

Q34022920-0BDD7A35-16FC-489D-9973-8FC39A342C9F

Q34022920-0C25EF36-AF30-4A92-85AE-A038DCDD711D

Q34022920-1488E399-FF5F-48CB-B7F9-D72D9CBA7836

Q34022920-24C8BBC7-9F0A-4499-87BE-59B330300BAF

Q34022920-30528092-0F76-4089-93E9-4B8C25866AE7

Q34022920-3817C5DC-255E-4AB0-98A0-7FCFC1553AEF

Q34022920-38504405-3215-4E9C-AAA4-BBE9DAA6F4FD

Q34022920-4C4287BB-6316-4AED-A39B-27928150A14B

P304

Q34022920-D24C4539-3746-427F-8465-B06F60C2684F

P31

Q34022920-E5675CAA-D1B7-4F11-9BB1-4FE3D340C6B9

P356

Q34022920-FF3EEF87-99D7-4646-B77D-94FE80061614

P433

Q34022920-FAF66373-FAEF-4402-88D8-56A4BF756632

P478

Q34022920-2FA408A4-DE0D-4244-811A-F5824EAAF4B1

P50

Q34022920-009CBB28-3ABE-4537-8E3E-7A92D85BC972

P577

Q34022920-DBC1967D-A126-4CE2-BCFD-65D4ABAAA236

P5875

Q34022920-01FAE5A8-8B6E-4EBC-9718-10AB8583B3BA

P698

Q34022920-14713654-8A98-4A7F-AAE0-1627725A290C

P932

Q34022920-AC26898C-5C07-4A69-91A2-693117C30100

P356

P1433

Annals of Neurology

P1476

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models

@en

P2093

Avtar Roopra

http://www.w3.org/2001/XMLSchema#string

Carl E Stafstrom

http://www.w3.org/2001/XMLSchema#string

Jeffrey C Ockuly

http://www.w3.org/2001/XMLSchema#string

Lauren Murphree

http://www.w3.org/2001/XMLSchema#string

Thomas P Sutula

http://www.w3.org/2001/XMLSchema#string

P2860

Neuroprotective and disease-modifying effects of the ketogenic diet

Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death

Supply and demand in cerebral energy metabolism: the role of nutrient transporters

Modification of seizure activity by electrical stimulation. II. Motor seizure

2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure

Cellular pathways of energy metabolism in the brain: is glucose used by neurons or astrocytes?

Mechanisms of epileptogenesis.

Clinical efficacy of the ketogenic diet.

Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy.

Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet.

P304

435-447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.21603

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Matthew T Valley

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24366870

http://www.w3.org/2001/XMLSchema#string

P698

19399874

http://www.w3.org/2001/XMLSchema#string

P932

2910719

http://www.w3.org/2001/XMLSchema#string